Scott Price, Vice President of Sales at Ren-Pharm International, Ltd. has been elected to serve on the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT) beginning November 1st, 2020. Together with 10 other members of DCAT’s Board of Directors, Mr. Price will help develop and guide the organizations strategic plan in a manner to best serve the organization’s 500 + member companies.
Click here to see complete press release.